KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Edwards Lifesciences (EW) over the last 16 years, with Q3 2025 value amounting to $669.7 million.

  • Edwards Lifesciences' Change in Acquisitions & Divestments rose 34439.28% to $669.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 25373.82%. This contributed to the annual value of $800.1 million for FY2024, which is 2948.7% up from last year.
  • Edwards Lifesciences' Change in Acquisitions & Divestments amounted to $669.7 million in Q3 2025, which was up 34439.28% from $611.8 million recorded in Q2 2025.
  • In the past 5 years, Edwards Lifesciences' Change in Acquisitions & Divestments registered a high of $827.9 million during Q1 2025, and its lowest value of $81.7 million during Q2 2021.
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $177.0 million (2022), whereas its average is $255.7 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first crashed by 5069.89% in 2023, then skyrocketed by 42631.91% in 2025.
  • Over the past 5 years, Edwards Lifesciences' Change in Acquisitions & Divestments (Quarter) stood at $129.1 million in 2021, then skyrocketed by 38.26% to $178.5 million in 2022, then decreased by 26.61% to $131.0 million in 2023, then skyrocketed by 99.24% to $261.0 million in 2024, then soared by 156.59% to $669.7 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $669.7 million for Q3 2025, versus $611.8 million for Q2 2025 and $827.9 million for Q1 2025.